Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Paul Weishaar (NPI 1548261696)

Field	Value
Entity Type	Individual
Organization	Paul Weishaar
Address	530 N Lorraine St
City	Wichita
State	KS
ZIP	67214
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	August 10, 2005

Payer Source	Total Paid
Medicare	$3.5M
Medicaid	$0

Key Findings

This provider is heavily revenue-driven by intravitreal biologic injections: J2777 generated $1.3M in revenue (38.9% of this provider's total Medicare revenue) with 46.3K claims, J0178 generated $1.2M (35.5%) with 1.8K claims, and J2778 generated $260.4K (7.5%) with 1.4K claims. The platform’s precomputed metric confirms that the top 3 Medicare codes (J2777, J0178, J2778) account for 81.9% of this provider's total Medicare revenue, indicating a concentrated drug/injection-focused service line rather than diversified outpatient revenue streams.

Payer mix is effectively single-payer Medicare: Total Medicare revenue is $3.5M and there is no Medicaid billing on file. That absence of Medicaid activity means Medicaid does not contribute to this provider’s revenue base, so Medicare reimbursement policy and drug pricing dynamics are likely to disproportionately influence business performance.

Clinical and operational profile aligns with a medical retina practice that pairs high-volume pharmacologic therapy with diagnostic imaging: 92134 appears as a high-volume imaging code with 2.9K claims and $74.5K in revenue (2.2%), ranking #460 of 26868 providers nationally (98th percentile; extreme outlier). Coupled with the injection volumes for J2777 and J0178, the mix suggests a workflow built around frequent intravitreal treatment visits supported by retinal imaging.

Evaluation-and-management volumes are unusually high relative to peers for a retina specialist: 99213 shows 1.7K claims and $96.5K revenue (2.8%), ranking #1485 of 457151 providers nationally (100th percentile; extreme outlier). This combination of very high E/M claims plus injection and imaging volumes implies a busy clinic with large established-patient throughput and frequent follow-up visits.

Provider shows meaningful surgical retina activity in addition to injections: 67036 has $35.5K revenue (1.0%) from 65 claims and ranks #49 of 832 providers nationally (94th percentile; notably above typical national volume), and 67041 generated $28.6K (0.8%) from 35 claims (87th percentile). These surgical CPTs indicate the practice performs a nontrivial number of posterior-segment procedures, so its capabilities span both ambulatory injections and operative retina care.

Competitive standing is mixed by code: for J2777 this provider ranks #124 of 2039 (94th percentile; notably above typical national volume), marking them as a high-volume national participant for faricimab administration. For J0178 and J2778 the ranks are #648 of 3204 (80th percentile) and #306 of 1208 (75th percentile) respectively, which are solid but more typical volumes compared with national peers.

Revenue concentration creates sensitivity to drug and coding trends: with the top 3 codes comprising 81.9% of Medicare revenue, shifts in utilization, reimbursement, or availability of J2777 or J0178 could materially affect overall revenue. Analysts should treat drug-code utilization trends and payer policy changes (especially around newer agents like faricimab) as the primary levers that would alter this provider’s financial profile.

This is an established practice with long tenure: the NPI was enumerated on 2005-08-10 (~21 years ago), indicating sustained participation in Medicare across multiple policy environments. That longevity, paired with high-volume injection, imaging, and E/M activity, supports characterization as an established retina specialist in Wichita, KS rather than a newly emergent practice.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

32 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	46,320	$30	$1.3M
J0178	Injection, aflibercept, 1 mg	1,770	$690	$1.2M
J2778	Injection, ranibizumab, 0.1 mg	1,420	$180	$260.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,900	$80	$159.8K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,690	$60	$96.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,870	$30	$74.5K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	360	$160	$57.9K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	70	$550	$35.5K
67041	In this procedure, the provider removes scar tissue from the retinal membrane that obscures vision. He removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical…	40	$820	$28.6K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	130	$220	$28.3K

Showing 1–10 of 32

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 32 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Paul Weishaar — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

32 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	14	30	1,770	$690	$1.3M
J2777	4	30	12,060	$30	$575.7K
J2778	9	20	860	$180	$297.6K
67028	12	40	1,170	$90	$111.4K
Q5128	3	10	290	$220	$83.5K
J7312	2	10	260	$160	$43.6K
67042	10	20	20	$1,140	$31.9K
67108	12	20	20	$1,130	$24.8K
J3590	11	20	200	$100	$24.1K
67036	1	10	20	$930	$21.4K

Showing 1–10 of 32

Related Providers

Other providers that share a Tax Identification Number (TIN) with Paul Weishaar, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0
Shaker Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Paul Weishaar, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Craig Resources LLC	KS	Home Health Agency	$0	$97.3M
Paradigm Services Inc	KS	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$42.4M
Wesley Medical Center LLC	KS	General Acute Care Hospital	$0	$30.2M
Gracemed Health Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$18.3M
Healthcore Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$15.3M
Diversified Family Services LLC	KS	Home Health Agency	$0	$13.9M
Alpha Service	KS	Developmentally Disabled Services Day Training Agency	$0	$12.1M
Carepoint Emergency Medicine Kansas LLC	KS	Emergency Medicine Physician	$0	$11.8M
Hunter Health Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$10.4M
Ascension Via Christi Hospitals Wichita Inc.	KS	General Acute Care Hospital	$0	$8.9M

Paul Weishaar — Billing Profile & Reimbursement Data

Sign up for Paul Weishaar — Billing Profile & Reimbursement Data policy alerts

Paul Weishaar — Billing Profile & Reimbursement Data

Sign up for Paul Weishaar — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References